Science & Medicine Group Expands as Commercial Data Insights Leader with Amplion Acquisition

Science and Medicine Group Inc.(SMG), a data intelligence company providing actionable insights about hard-to-reach audiences in life sciences and healthcare, announced that it has acquired the assets of Amplion Inc., an innovator in AI-powered data intelligence for life science marketing and sales teams seeking to identify business opportunities and accelerate sales growth.

Amplion's machine learning-based capabilities enable commercial teams to precisely target the right accounts and most appropriate, and often hard-to-reach, decision makers in pharma, biotech and academia. The Amplion platform and intuitive browser-based user interface provides new levels of hyper-personalized targeting, prospecting, scalability, speed and automation to improve sales and marketing far beyond conventional methods and existing manually searched contact databases.